ロード中...
Apalutamide: Emerging Therapy for Non-Metastatic Castration-Resistant Prostate Cancer
Prostate cancer is the second deadliest cancer in the US and the fourth most common cancer among Saudi males. Patients usually present with non-metastatic disease and treated with localized therapy. However, up to 40% of the patients will experience biochemical recurrence, within 10 years. Androgen...
保存先:
| 出版年: | Saudi Pharm J |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6438706/ https://ncbi.nlm.nih.gov/pubmed/30976180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsps.2018.12.005 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|